Most side effectsnausea, constipation, and reduced appetiteactually drive the weight loss mechanism
None of these studies should be interpreted as recommending Retatrutide GLP-3 for human use, treatment, or any clinical purpose
Asakura T, Sasagawa A, Takeuchi H, Shibata S, Marushima H, Mamori S et al
the most common are nausea, diarrhea, constipation, and vomiting, which are usually mild and tend to improve over time
Methodology The study included a random nationwide sample (n=655) of patients treated with branded semaglutide (Wegovy or Ozempic) through Ro's platform who persisted with treatment and reported their weight at 68 weeks (14 days)